SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093325
Filing Date
2024-08-08
Accepted
2024-08-08 07:25:42
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20240630.htm   iXBRL 10-Q 2290111
2 EX-10.1 caba-ex10_1.htm EX-10.1 42574
3 EX-31.1 caba-ex31_1.htm EX-31.1 16667
4 EX-31.2 caba-ex31_2.htm EX-31.2 16644
5 EX-32.1 caba-ex32_1.htm EX-32.1 9374
6 EX-32.2 caba-ex32_2.htm EX-32.2 9883
  Complete submission text file 0000950170-24-093325.txt   7811142

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20240630.xsd EX-101.SCH 894771
60 EXTRACTED XBRL INSTANCE DOCUMENT caba-20240630_htm.xml XML 1321484
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 241186052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)